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A B S T R A C T
Background and purpose: Patients with Moyamoya Disease (MMD) need hemodynamic evaluation of vascular
territories at risk of stroke. Today's investigative standards include H215O PET/CT with pharmacological chal-
lenges with acetazolamide (ACZ). Recent developments suggest that CO2-triggered blood‑oxygen-level-depen-
dent (BOLD) functional MRI might provide comparable results to current standard methods for evaluation of
territorial hemodynamics, while being a more widely available and easily implementable method. This study
examines results of a newly developed quantiﬁable analysis algorithm for CO2-triggered BOLD MRI in
Moyamoya patients and correlates the results with H215O PET/CT with ACZ challenge to assess comparability
between both modalities.
Methods: CO2-triggered BOLD MRI was performed and compared to H215O PET/CT with ACZ challenge in pa-
tients with angiographically proven MMD. Images of both modalities were analyzed retrospectively in a blinded,
standardized fashion by visual inspection, as well as with a semi-quantitative analysis using stimuli-induced
approximated regional perfusion-weighted data and BOLD-signal changes with reference to cerebellum.
Results: 20 consecutive patients fulﬁlled the inclusion criteria, a total of 160 vascular territories were analyzed
retrospectively. Visual analysis (4-step visual rating system) of standardized, color-coded cerebrovascular re-
serve/reactivity maps showed a very strong correlation (Spearman's rho= 0.9, P < 0.001) between both
modalities. Likewise, comparison of approximated regional perfusion changes across vascular territories (nor-
malized to cerebellar change) reveal a highly signiﬁcant correlation between both methods (Pearson's r=0.71,
P < 0.001).
Conclusions: The present analysis indicates that CO2-triggered BOLD MRI is a very promising tool for the he-
modynamic evaluation of MMD patients with results comparable to those seen in H215O PET/CT with ACZ
challenge. It therefore holds future potential in becoming a routine examination in the pre- and postoperative
evaluation of MMD patients after further prospective evaluation.
1. Introduction
Moyamoya Disease (MMD) is characterized by a bilateral pro-
gressive stenosis of the Circle of Willis with ﬁne collateral networks
resembling a puﬀ of smoke, giving the disease its name (Suzuki and
Takaku, 1969). The most common initial symptoms are transient is-
chemic attacks (TIAs) and ischemic or hemorrhagic strokes caused by
an insuﬃcient cerebral perfusion. To prevent recurrence of such events,
microsurgical revascularization is indicated in many patients (Khan
et al., 2003; Scott and Smith, 2009; Guzman et al., 2009). Before in-
dicating a surgical revascularization, identiﬁcation of cerebral vascular
territories with insuﬃcient perfusion is crucial to ensure a successful
tailored treatment for each patient. This, however cannot be achieved
with routine MRI and digital subtraction angiography (DSA) alone, but
hemodynamic modalities like H215O positron emission tomography
(PET) or Single Photon Emission Computed Tomography (SPECT) with
acetazolamide (ACZ) challenge, among others, remain indispensible
(Pandey and Steinberg, 2011; Lee et al., 2009; Roder et al., 2018; Acker
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Fig. 1. A) Plot of mean signal intensities in all evaluated regions over the course of the whole fMRI measurement. Vertical lines show the breath-hold time periods of
9 s each. B) Shows response curves of the cerebellum as a reference. In this case, the ﬁfth cycle (grey color) shows a markedly diﬀerent response curve suggestive of
poor patient compliance in this cycle. For further analysis this cycle was excluded. C) Peristimulus histograms (PSTH) showing breath hold related signal increase in
the ACA (blue), MCA (green) and PCA (red) territories compared to the reference curve of the cerebellum (yellow). Top left shows an overview with mean curves
representing the ACA, MCA and PCA signals of both hemispheres. This patient with unilateral involvement of Moyamoya angiopathy shows nearly normal response
curves in the left MCA, whereas there is a negative curve amplitude in the right sided MCA territory, indicating ﬂow reduction during breath hold- induced vessel
dilatation. D) CVR maps of breath-hold BOLD MRI indicating the above-mentioned vascular deﬁcits. Values for the color-scale resemble the integral of the relative
signal change of BOLD MRI. E) Corresponding FLAIR images. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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et al., 2018). Main disadvantages of H215O PET with ACZ challenge
include high costs and limited availability. Although the radiation ex-
posure due to injection of H215O is very low (especially with modern
scanners) and side-eﬀects due to ACZ are very rare and usually tran-
sient, this may be of concern in special patients (e.g., in pediatric pa-
tients). Throughout the last decades new approaches have been pursued
to overcome some of these drawbacks. More advanced imaging at-
tempts used MR-based arterial spin labeling (ASL), CO2-triggered
blood‑oxygen-level-dependent (BOLD) and even resting-state functional
MRI techniques, which could be used without any intravenous contrast
agent injections (Liu et al., 2017; Shiino et al., 2003; Sam et al., 2015;
Pellaton et al., 2016; Mikulis et al., 2005; Mazerolle et al., 2018;
Mandell et al., 2008; Heyn et al., 2010; van Niftrik et al., 2016; Fierstra
et al., 2013; Donahue et al., 2014; Bright and Murphy, 2013; Fierstra
et al., 2018). A contemporary consensus statement of diﬀerent imaging
methods for diagnosis and evaluation of cerebrovascular disease was
recently published by Donahue et al. (2018) Of these, CO2-triggered
BOLD MRI seems to be one of the most promising tools for evaluation of
cerebral hemodynamics. This technique uses the physiological vasodi-
latory eﬀect of CO2 to alter the amount of deoxy-hemoglobin in venules
by blood ﬂow increase due to arteriole smooth-muscle-cell relaxation
with constant cerebral metabolic rate of oxygen, which can be mea-
sured with BOLD MRI. Therefore, the change between baseline BOLD
signal can be compared to the signal after CO2-triggered vasodilation,
resulting in a signal change which is most commonly called the cere-
brovascular reactivity (CVR) (Liu et al., 2017; Heyn et al., 2010).
Triggers for the changes of CO2 concentrations can either be exogenous
with breathing masks delivering diﬀerent concentrations of gas, or
endogenous by breathing pauses – commonly called breath-hold
(Fierstra et al., 2013).
In the present retrospective study, we thus pursued a systematic
comparison of the cerebral perfusion reserve (CPR), measured with
H215O PET/CT with ACZ challenge, and CO2-triggered BOLD MRI for
assessment of CVR in patients with MMD. To this end, we compared not
only standardized, color-encoded CPR and CVR maps gained by both
modalities (as done in clinical routine) but also contemplated the cor-
relation between approximated regional perfusion changes across vas-
cular territories.
2. Material and methods
A retrospective analysis of consecutive adult patients at our
Moyamoya Center was performed. Main inclusion criteria were angio-
graphically proven Moyamoya angiopathy, the availability of H215O
PET/CT with ACZ challenge and a CO2-triggered BOLD MRI with a
chronological proximity of both examinations of< 6months with no
surgical intervention in-between. Pre- and postoperative examinations
were included, the analysis was performed combined and in sub-
groups. If indicated, the surgical intervention was performed by a direct
STA-MCA and/or direct or indirect STA-ACA (EDAS - encephala-duro-
arterio-synangiosis or EGPS – encephalo-galea-periost-synagiosis) by-
pass. Ethical approval was obtained at the University of Tübingen
Ethics Committee. General patient data were obtained from the pa-
tients' clinical ﬁles, any imaging data was stored and analyzed in the
hospital's PACS system.
2.1. MR data acquisition
All MR images were acquired on a 3 T MR Scanner (Magnetom
Skyra, Siemens, Erlangen, Germany) using a 20-channel head coil
during a routine clinical MRI scan. The dynamic data was measured by
means of a whole brain 2D T2*-weighted echo-planar sequence scanned
parallel to the anterior-posterior commissure. (TR= 3000ms,
TE= 36ms, matrix 96×96, 3mm slice thickness, 34 slices in inter-
leaved ascending order, FOV=245mm, resolution 2.6×2.6× 3.0,
TA 6:53, 135 measurements). The protocol consisted of 60 s of normal
breathing (20 measurements) followed by 5 repetitive cycles of 9 s
breath-hold in expiration (3 measurements) and 60 s of regular
breathing (20 measurements) (see also Fig. 1). The patient breathing
instructions were presented visually via a wall-mounted display and a
mirror ﬁxed to the head coil. Presentation V20.1 (Neurobehavioral
Systems, Berkeley, CA, USA) was used to present scanner triggered
stimuli.
2.2. MR data processing
Preprocessing of the resulting 135 functional datasets was per-
formed in SPM12 (The Wellcome Dept. of Imaging Neuroscience,
London; www.ﬁl.ion.ucl.ac.uk/spm). After conversion of DICOM
images to nifti format, slice timing correction was used to equalize time
of image acquisition. Images were then realigned so that patient head
movements were compensated. As the last step the datasets were spa-
tially normalized to a standard MNI (Montreal Neuroimaging Institute)
space and smoothed by a 12mm full with half maximum ﬁlter.
2.3. MR map and curve calculation
The data was further analyzed by a script programmed in MATLAB
R2017b (The MathWorks, Inc., Natick, Massachusetts; http://www.
mathworks.com).
The ATT (arterial transit time) (Mutsaerts et al., 2015) based ﬂow
territory atlas was used to generate volumes of interest (VOIs) for
anterior cerebral artery (ACA left and right), middle cerebral artery
(MCA left and right), posterior cerebral artery (PCA left and right) and
cerebellar vascular territories (left and right). Raw data of signal change
for each territory in relation to the breath-hold cycles is displayed in
Fig. 1A.
Mean cerebellar signal intensity of the fMRI data was calculated and
displayed for all 5 breath-hold cycles (Fig. 1B). This was used to verify
patient compliance and overall signal quality. At this time, individual
breath-hold cycles could be excluded from further evaluation if the
reference signal (cerebellum) showed no suitable signal curve in visual
inspection (Fig. 1B, grey curve).
All included breath-hold cycles were averaged. With the resulting
respective 23 fMRI datasets a VOI-mean was calculated, which was then
used to set the beginning and end points of the breath-hold related
signal increase. As the time of onset of the breath-hold related ﬂow
response varied in patients (diﬀerent physiological characteristics,
chronologic variation in collaboration of starting to hold the breath),
the reference VOI (cerebellum) was used to manually set the start and
end timepoint of the ﬂow response.
For each voxel (volume element) in the 3D dataset, the signal curve
was de-trended to remove linear signal changes over time. The relative
signal change was then computed by dividing the signal at each point in
the curve by the curve mean to account for diﬀerences in initial signal
intensity of the epi imaging sequence. This time-course of signal in-
tensity was then displayed as signal change for each vascular territory
(Fig. 1C).
After up-sampling the data, the integral of the curve between the
start and end point was calculated for each voxel resulting in a 3D in-
tegral map which was then displayed as an overlay on a normalized
standard brain (Fig. 1D).
2.4. H215O PET/CT with ACZ challenge
PET scans were acquired either on a Philips Gemini TF64 PET/CT
(n=14; until 12/2017) or a Philips Vereos digital PET/CT system
(n=6; from 01/2018 onward; Philips, The Netherlands). We did not
pursue absolute quantiﬁcation of regional cerebral blood ﬂow (CBF; in
terms of ml/min/100 g brain tissue) by continuous arterial blood
sampling and kinetic modeling. Instead we used a simpliﬁed method to
estimate cerebral perfusion reserve (CPR) as proposed by Arigoni et al.
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(2000) After a low-dose CT for attenuation correction, four 4-min scans
were acquired per patient. The head position was gently restrained by a
tape, carefully monitored and, if necessary, corrected throughout the
procedure by means of reference skin marks and the scanner laser
beam. Scans before and after ACZ injection were done in duplicate (10-
min interval between H215O injections to allow for suﬃcient decay)
under resting conditions (i.e., eyes open and ears unplugged at normal
ambient light and noise). A standard dose of 1000mg ACZ (except in
three patients who received 500 to 800mg because of low body weights
of 44–57 kg) was dissolved in 50ml water for injection and adminis-
tered immediately after the end of the 2nd baseline scan as an infusion
over 5min. The 3rd PET scan was started 10min (5min) after the start
(end) of the ACZ infusion. A standard dose of 300MBq H215O (10ml
volume) (except in one patient with low body weight examined with
the Vereos scanner, who received 250MBq per injection) was injected
at the start of each PET scan as a bolus over 3 s into a cubital vein. Data
sets of the Gemini scanner were reconstructed using the line-of-re-
sponse row-action maximum likelihood expectation algorithm (LOR-
RAMLA) 3D iterative reconstruction algorithm (number of itera-
tions= 3, number of subsets= 33, resulting voxel
size= 2.0×2.0× 2.0mm3) into a dynamic sequence of 15 frames
(6× 5 s, 3×10 s, 3×20 s, 2×30 s and 1× 60 s), whereas the data of
the Vereos scanner were reconstructed by using line-of-response time-
of-ﬂight ordered subsets 3D iterative reconstruction algorithm em-
ploying spherically symmetric basis functions (so-called BLOB-OS-TF
reconstruction; number of iterations= 3, number of subsets= 11, re-
sulting voxel size= 2.0×2.0× 2.0mm3) yielding a dynamic sequence
of 30 frames (18× 5 s, 9×10 s and 3× 20 s) per scan. All datasets
were fully corrected (attenuation, scatter, randoms, normalization and
calibration) during iterative reconstruction.
For simpliﬁed voxel-wise calculation of CPR maps, all scans of each
subject were corrected for motion and integrated over 60 s (Vereos) or
70 s (Gemini) after arrival of the tracer in the individual patient's brain
(Arigoni et al., 2000). The start time of integration was determined by
analyzing the time-activity curve with a whole brain region of interest
(ROI; 35% of maximum isodensity contour) covering a 5-cm slab at the
level of the basal ganglia. Voxel-wise estimate of CPR (CPR map) were
calculated using the SISCOM methodology (O'Brien et al., 1998). In
brief, the two integral scans before and after ACZ were averaged and
then masked using a threshold of 25% of the image maximum (whole-
brain segmentation). Voxel-wise signal change (in percent) from base-
line status to the status after ACZ administration was calculated and the
resulting parametric map was smoothed (Gaussian ﬁlter, 12mm
FWHM) and masked again (see above), yielding the desired CPR map.
For visual reads, the average integrated scans before and after ACZ and
the CPR map were co-registered to the patients' MRI and displayed in a
standardized fashion (typically 32 transaxial planes covering the entire
brain; average integrated scans were displayed using an identically
thresholded “rainbow” color-scale, while a “cold” color-scale was used
for CVR maps). Finally, for ROI analysis of vascular territories, afore-
mentioned images were normalized to the MNI-152 PET template and a
ROI set comprising bilateral ACA, MCA and PCA territories (ATT based
ﬂow territories, Tatu et al. (1998)) was applied. Since this ROI template
lacks ROIs for bilateral striatum, thalamus and cerebellum, these ROIs
were generated from the adult brain maximum probability map
‘Hammersmith atlas n30rb83’ (Hammers et al. (2003) for striatum and
thalamus) and the SUIT atlas (Diedrichsen (2006) for cerebellum).
Accurate ROI alignment was veriﬁed by visual inspection in all cases.
The commercial software packages PMOD (version 3.7; PMOD Tech-
nologies LLC, Switzerland) and Matlab (The MathWorks, Inc., Natick,
Massachusetts, United States), as well as the freely available Statistical
Parametric Mapping (SPM 12, http://www.ﬁl.ion.ucl.ac.uk/spm/)
were used for the aforementioned analyses.
2.5. Comparative analysis of PET and MR BOLD data
A blinded analysis of all CPR and CVR color maps (PET and Breath
hold fMRI) was performed independently by two experienced neuror-
adiologists. Each vascular territory (anterior-(ACA), middle-(MCA),
posterior-(PCA) cerebral artery as well as cerebellar) was graded se-
parately for each hemisphere. The visual grading was based on four
grades according to each territory's reserve/reactivity: 1) normal 2)
mild decrease in cerebrovascular reserve/reactivity 3) strong decrease
in cerebrovascular reserve/reactivity 4) no or negative cerebrovascular
reserve/reactivity compared to normal.
The interrater-reliability was calculated. Evaluation of any territory
with diﬀering results between both raters, was decided in consensus
with a third rater.
For the semi-quantitative comparison of perfusion changes, the
approximated relative regional perfusion change (percentage change
between baseline and ACZ or CO2 trigger) was assessed by both mod-
alities for each supratentorial vascular territory (separated by site) as
well as the cerebellum. Furthermore, approximated relative regional
perfusion changes were normalized to the cerebellar perfusion change
for optimal comparability of both modalities. This was done to remove
systematic individual (e.g., day-to-day variations) and methodological
(e.g., diﬀerent magnitude of vasodilatatory stimulation) variations,
which should aﬀect supratentorial target regions and the reference re-
gions to a similar extent and, thus, cancel out.
Additionally, we have separated the analysis in two patient groups,
namely pre- and postoperative (after surgical revascularization) ex-
aminations. This is based on the fact, that the validity of CO2 BOLD
imaging should be proven for both cohorts separately.
2.6. Statistical analysis
Data was analyzed with Graph Pad Prism (v7.04, GraphPad
Software Inc., La Jolla, CA, USA). Categorical data were presented as
frequencies, inter-rater agreement was calculated using Cohen's kappa
statistics with weighted analysis. Correlation of data was calculated
with Pearson's and Spearman's correlation coeﬃcient (r and rho, re-
spectively) for parametric and non-parametric samples, respectively.
The two-tailed p-value was accepted to be signiﬁcant at p < 0.05.
3. Results
Twenty consecutive MMD patients fulﬁlled the inclusion criteria.
General clinical data can be found in Table 1. The total number of
vascular territories analyzed was 160. If patients had a surgical re-
vascularization, the postoperative imaging took place at least one year
after the surgery. CO2 triggered BOLD MRI was accurately performed in
all patients, as supported by the visual analysis of the cerebellar BOLD
signal curves. H215O PET with ACZ challenge showed adequate re-
sponse of ACZ in all patients (average cerebellar CPR 34 ± 11%).
3.1. Correlation analysis of visual inspection of anatomical color maps
Cohen's Kappa (weighted) for the interrater-agreement between
Table 1
Overview of general patient data.
General patient data
Mean age (range) 40.2 (16–67)
Female:Male ratio 18:2
Unilateral Moyamoya Angiopathy 5 (25%)
Bilateral Moyamoya Disease 15 (85%)
Imaging before revascularization 11 (55%)
Imaging after revascularization 9 (45%)
Revascularized territories at the time of imaging (range) 22 (1–4)
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both raters was 0.95, indicating excellent agreement. The visual ana-
lysis of signal change in the respective vascular territory on color-coded
maps revealed very strong correlation of the results of CO2 BOLD MRI
and H215O PET/CT with ACZ challenge (rho= 0.90, p < 0.001).
Diﬀerences between the visual ratings (grade 1–4) between both
modalities were found in 25 of 160 (15.6%) territories, all these dif-
fered by only one grade. The correlation was comparably good for
groups separated to pre- (rho=0.90, p < 0.001) and postoperative
(rho= 0.91, p < 0.001) cohorts. Table 2A shows the distribution of
aﬀected vascular territories for both modalities according to the visual
analysis. We have also analyzed all territories in which the results of
CO2 BOLD MRI and PET diﬀered. The results can be found in Table 2B.
In summary, we did not see a systematic diﬀerence in terms of over- or
underestimation of any of both technologies in comparison to the other.
3.2. Correlation analysis of approximated regional perfusion changes
The analysis of absolute values of signal change in the respective
territories did not show a very high correlation due to the diversity of
signal-source in image acquisition by BOLD MRI and PET. There was a
weak, albeit signiﬁcant correlation between approximated regional
perfusion/reactivity changes yielded by both modalities across the
territories in all patients (r=0.35, p=0.001; Fig. 2A).
3.3. Correlation analysis of approximated regional perfusion/reactivity
changes normalized to cerebellum
For semi-quantiﬁable correlation of BOLD MRI (cererbrovascular
reactivity) and PET (cererbral perfusion reserve) data were normalized
to the cerebellum. The analysis of all 120 supratentorial vascular ter-
ritories revealed a strong, highly signiﬁcant correlation between both
imaging modalities (r=0.71, p < 0.001). Separate analysis of pre-
and postoperative subgroups yielded similar results (r=0.61,
p < 0.001 and r=0.76, p < 0.001, respectively; Fig. 2B–D).
4. Discussion
CO2-triggered BOLD MRI has developed signiﬁcantly since its ﬁrst
descriptions and has the potential to become a routine tool for the
evaluation of the cerebrovascular reactivity in the future (Liu et al.,
2017; Shiino et al., 2003; Sam et al., 2015; Pellaton et al., 2016; Mikulis
et al., 2005; Mazerolle et al., 2018; Mandell et al., 2008; Heyn et al.,
2010; van Niftrik et al., 2016; Fierstra et al., 2013; Donahue et al.,
2014; Bright and Murphy, 2013; Kastrup et al., 2001). The studies
performed to date have focused on the image-acquisition techniques
and their optimization as well as aim at critically comparing it with
other imaging modalities. In MMD where the patients vary in severity
of angiopathy and collateral formation, the evaluation of cerebral re-
serve capacity is not possible with angiography and MRI alone (Roder
et al., 2018), hence necessitating additional hemodynamic imaging
such as H215O PET with ACZ challenge. Less expensive, without the
need of an intravenous injection, more widely available and easy to
implement BOLD MRI may be able to substitute these in the future.
In the present study we demonstrate a highly signiﬁcant, good to
excellent correlation between regional assessments of CPR by H215O
PET/CT with ACZ challenge and CVR assessment with breath-hold
BOLD MRI in MMD patients based on visual ratings (rho=0.9; no
systematic diﬀerence) and normalized regional analyses (r=0.71).
4.1. Selection of stimulus for CO2-changes in the BOLD-based measurement
of cerebrovascular reserve
We used the breath-hold technique to trigger hypercapnia, which
results in cerebral vasodilatation and therefore enables the evaluation
the CVR. No doubt, this technique, relying on the cooperation of pa-
tients and on individual physiological factors (i.e. individual lung size
and metabolism) is not a strictly standardized stimulus. Fierstra and
colleagues discussed the issue of measuring the CVR with the best sti-
mulus extensively, and conclude that vasoactive substances (such as
ACZ), medically induced hypotension and breath-hold triggered hy-
percapnia are not appropriate for reproducible results, and recommend
the use of a computer-controlled gas delivery system for repeatable
vasoactive stimuli (Fierstra et al., 2013). Of note, the possible inter-
individual variation and the diﬀerence between both stimuli (breath-
hold and ACZ) also motivated us to contemplate normalized regional
CVR estimates.
We agree that a controlled gas delivery system would eliminate the
need for patient cooperation thus might lead to more reliable results
also in patients with limited compliance. However, patients with such
limited compliance might also not be able to remain without relevant
head movement for the time of scanning without sedation and might
therefore be generally inappropriate for this examination. A recent
study proved that also children with a mean age of 12 years were able
to collaborate in repeated breath-hold MR examination with good
correlation (Dlamini et al., 2018).
Computer-controlled gas delivery devices are not widely available
and need patient monitoring during CO2 administration. Also, the
baseline EtCO2 might be manipulated by closed rebreathing systems,
which might also bias the results of such examinations. FMRI using
breath-hold as a vasodilatory trigger can be performed at nearly every
hospital since most (all) modern scanners are able to acquire 2D epi
images and patient instructions can be presented visually or via spoken
instructions through the headphones.
To overcome above-mentioned disadvantages of a gas-delivery
system and if the evaluation of the CVR of an individual patient is the
goal, the breath-hold technique as used here seems reliable and suﬃ-
cient. We have control of adequate application of the stimulus / pa-
tients' cooperation by analyzing the change of the BOLD signal over 5
breath-hold cycles by visual inspection of the cerebellum data. If in-
dividual cycles do not have an adequate signal change for any reason,
they can be excluded from the analysis. Further, by analyzing the semi-
quantitative cerebellar quotient, absolute inter-individual physiologic
changes to a stimulus are less meaningful due to intra-individual results
of each examination.
However, if the answer of speciﬁc physiologic questions or absolute
comparability between individuals are the goal of an examination or
study, a replicable and controllable stimulus ﬁtted to each individual
Table 2
A: Overview of frequency of grade of disease-aﬀection of the respective terri-
tories for each modality. B: Over- and underestimation of the respective mod-
alities shown by diverse ratings of individual territories of each modality. The
table shows the number of territories with diﬀering estimation of the respective
grade (1–4) of the cerebrovascular reserve/reactivity between both modalities.
No speciﬁc patterns of over- and/or underestimation in each of both modalities
could be seen.
A
Grade of aﬀection fMRI PET
1 91 89
2 25 27
3 23 24
4 21 20
B
Over- and underestimation fMRI PET Number of territories
(grade found in respective imaging modality) 1 2 8
2 1 6
2 3 3
3 2 3
3 4 2
4 3 3
Total 25
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patient should be used with any additional eﬀorts needed. For such
eﬀorts, a computer-controlled gas delivery system might be the better
choice.
4.2. Risk of wrong estimation of the cerebrovascular reactivity
Visual analysis of color-coded maps of regional cerebrovascular
reserve/−reactivity is the most commonly used way to interpret results
for the respective territories. In our analysis we did not have a single
patient/vascular territory with an entirely discrepant visual estimation
of the CVR in comparison to the CPR in PET. If divergent, both mod-
alities did not diﬀer more than one grade of our four-step visual eva-
luation system.
Further, a special ﬁnding of BOLD MRI needs to be mentioned:
Negative quotients for vasoreactivity were seen in 4 vascular territories
in BOLD MRI. These territories were also severely aﬀected with a sig-
niﬁcantly decreased perfusion reserve in PET (quotient normalized to
the cerebellum below 0.5, which was only be seen in very few terri-
tories (see Fig. 2)), yet not negative. Whether such ﬁndings in BOLD
MRI resemble a vascular stealing phenomenon, or just an artifact by
delayed vasodilatation in the acquisition of BOLD MRI, remains un-
certain and is discussed controversially in the literature (Mandell et al.,
2008; Watchmaker et al., 2019; Fierstra et al., 2010). However, all
territories with negative vasoreactivity in BOLD MRI proved to be se-
verely aﬀected in PET CT as well, and would have therefore not resulted
in a wrong estimation from a clinical point of view.
On purpose we did not include a cut-oﬀ value to indicate a possible
surgical revascularization for this analysis, which we also do not use in
our current clinical routine with PET. Clinical decision making must
always be based on the entire available spectrum of imaging modalities,
namely conventional MRI and angiography plus additional quantitative
ACZ-challenge cerebrovascular imaging, such as PET, or possibly CO2-
triggered BOLD MRI in the future (see exemplary case Fig. 3).
4.3. Limitations
Main limitation of this study is the retrospective assessment and
limited number of patient data for this study. Yet, this is the ﬁrst series
of a patient cohort with angiographically proven MMD and standar-
dized comparison (visual ratings and semi-quantitative analyses) of
H215O PET with ACZ challenge and breath-hold BOLD MRI. The time
between both imaging modalities was up to 6months with no surgical
intervention in between. A change in CVR might have occurred in pa-
tients within this time, yet this would be a very uncommon rapid dis-
ease progression of clinically stable Moyamoya patients. Therefore, we
think that this fact may not limit the impact of this study's ﬁndings. As
discussed above, the breath-hold stimulus might show some inter-in-
dividual variation, which however might not be of overriding im-
portance as comparison of changes between pre- and post-stimulus is
evaluated in individuals only and not for the entire cohort. It should
Fig. 2. Plots showing the correlation of all signal changes for PET (x-axis) and fMRI (y-axis). A) shows the correlation of absolute values of signal change showing a
weak, but signiﬁcant correlation (r=0.35, p=0.001). B–D) shows values calculated as the quotient of absolute values in the respective vascular territories and
signal of the cerebellum with strong correlation. B) depicts territories of all patients (r=0.71, p < 0.001), C) of all patients with preoperative (r=0.61, p < 0.001)
and D) of all patients with postoperative imaging (r=0.76, p < 0.001).
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also be addressed that a short breath-hold stimulus of 9 s was used.
Therefore, results might be inﬂuenced by variable arterial circulation
times and collaboration of these patients. However, adequate colla-
boration of patients is controlled by replicable changes of cerebellar
BOLD MRI signal change, making this approach reliable for clinical use,
as also shown in other studies (Bright and Murphy, 2013; Dlamini et al.,
2018). Further we did not use absolute quantiﬁcation of CBF by PET,
but a simpliﬁed approximation of CPR and intra-individual normalized
values for comparison with MRI. Future prospective studies, also in-
cluding absolute quantiﬁcation of CBF-PET, are needed for proper va-
lidation of breath-hold BOLD MRI.
5. Conclusions
CO2-triggered breath-hold BOLD MRI seems to be a promising tool
for the evaluation of the CVR in patients with Moyamoya and correlates
well with the results of ACZ-triggered cerebrovascular reserve evalua-
tion on H215O PET/CT. This technique represents a less expensive and
widely available method for the evaluation of hemodynamics in pa-
tients with Moyamoya Disease. Further prospective studies are needed
to explore its potential as a widely implementable tool for routine
clinical imaging.
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